Abstract
Neonatal multisystem inflammatory syndrome (MIS-N) is an emerging condition associated with perinatal exposure to SARS-CoV-2 and characterized by a systemic hyperinflammatory response with multiorgan involvement. Although it is a rare condition, early recognition is essential due to the potential cardiovascular complications, which may manifest as myocardial dysfunction or coronary artery dilation. We report the case of a preterm male newborn delivered at 34 weeks of gestation with a birth weight of 1490 g, born to a mother with a history of respiratory illness compatible with COVID-19 during pregnancy. The infant was delivered by emergency cesarean section due to fetal distress and presented neonatal depression and respiratory distress syndrome requiring mechanical ventilation and surfactant administration. During his stay in the neonatal intensive care unit, he developed multisystem involvement characterized by severe thrombocytopenia, anemia, necrotizing enterocolitis, neonatal seizures, and grade II intraventricular hemorrhage. Echocardiography revealed dilation of both coronary arteries and mild pericardial effusion. Laboratory tests demonstrated elevated inflammatory and cardiac biomarkers, including troponin, NT-proBNP, ferritin, interleukin-6, and D-dimer. Based on the suspicion of MIS-N associated with SARS-CoV-2 exposure, treatment with intravenous immunoglobulin, methylprednisolone, and anticoagulation with enoxaparin was initiated, in addition to intensive neonatal support. The patient showed favorable clinical evolution with progressive normalization of inflammatory markers and resolution of coronary dilation on follow-up echocardiography. This case highlights the importance of considering MIS-N in neonates with multisystem involvement and elevated inflammatory markers in the context of perinatal exposure to SARS-CoV-2.

This publication has 17 references indexed in Scilit: